The combination of Corning’s competitive advantages across its business gives us confidence that it will earn returns on invested capital in excess of its cost of capital for the better part of the ...
Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback